Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  BASF    BAS   DE000BASF111

BASF (BAS)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Tradegate - 09/26 07:32:01 am
80.03 EUR   +0.25%
09/25BAS : Basf
AQ
09/24U.S. Reliance on Obscure Imports From China Points to Strategic V..
DJ
09/20BASF : introduces latest scientific findings at IFSCC Congress 2018
AQ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets
OFFRE

BASF seeks EU antitrust approval to buy Bayer assets

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/08/2018 | 12:55pm CEST
FILE PHOTO: A logo is seen on the facade of the BASF plant in Schweizerhalle

BRUSSELS (Reuters) - Germany's BASF (>> BASF) has asked for European Commission approval to buy assets from drugmaker Bayer (>> Bayer), the company which needs to shed businesses to get clearance for its $63.5 billion (45.76 billion pounds) merger with Monsanto (>> Monsanto), a filing showed.

BRUSSELS (Reuters) - Germany's BASF has asked for European Commission approval to buy assets from drugmaker Bayer, the company which needs to shed businesses to get clearance for its $63.5 billion (45.76 billion pounds) merger with Monsanto, a filing showed.

The Commission, which gave no further details on the deal being examined, set a preliminary deadline of April 16 to decide on the matter.

The Commission, which acts as competition watchdog in the European Union, added its assessment of the BASF request did not automatically mean it was satisfied with the commitments made by Bayer.

Earlier this year, Bayer said it had made "very significant" concessions to the Commission, adding it was confident they would fully address competition concerns.

Bayer has already pledged to sell certain seed and herbicide assets for 5.9 billion euros ($7.2 billion) to BASF and is also in talks to sell its vegetable seeds business.

(Reporting by Robert-Jan Bartunek; editing by Jason Neely and David Evans)

Stocks treated in this article : Monsanto, Bayer, BASF
Stocks mentioned in the article
ChangeLast1st jan.
BASF -1.36% 79.83 Delayed Quote.-12.98%
BAYER -0.72% 75.6 Delayed Quote.-25.60%
MONSANTO 0.00%-End-of-day quote.9.57%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on BASF
09/25BASF : Germany taking the lead on green power
AQ
09/25BASF : PHL to hold programs to provide students better understanding of science
AQ
09/25BAS : Basf
AQ
09/24U.S. Reliance on Obscure Imports From China Points to Strategic Vulnerability
DJ
09/23BASF INDIA : Quarterly results - basf india limited
AQ
09/22BASF : introduces poles for telcos and power producers
AQ
09/22BASF : launches Infinergy production in Changhua
AQ
09/21CATALENT : Lipid-Based Drug Delivery in Modern Pharmaceutical Development to be ..
AQ
09/20BASF : introduces latest scientific findings at IFSCC Congress 2018
AQ
09/20CATALENT : Lipid-Based Drug Delivery in Modern Pharmaceutical Development to be ..
AQ
More news
News from SeekingAlpha
09/24GAZPROM : Political Risk Lifts Over Nordstream 2 
09/19Germany reiterates view of Nord Stream 2 pipeline as private venture 
09/17BASF : Too Cheap To Ignore 
09/03ROAD TO FINANCIAL INDEPENDENCE : Growing Dividends, Endless Opportunities But Li.. 
08/31Nord Stream 2 construction begins in German coastal waters 
Financials (€)
Sales 2018 66 543 M
EBIT 2018 8 611 M
Net income 2018 5 476 M
Debt 2018 17 759 M
Yield 2018 4,07%
P/E ratio 2018 13,06
P/E ratio 2019 11,90
EV / Sales 2018 1,37x
EV / Sales 2019 1,27x
Capitalization 73 322 M
Chart BASF
Duration : Period :
BASF Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BASF
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 100 €
Spread / Average Target 26%
EPS Revisions
Managers
NameTitle
Martin Brudermüller Chairman-Executive Board
Jürgen Hambrecht Chairman-Supervisory Board
Hans-Ulrich Engel Chief Financial Officer & Vice Chairman
Michael Diekmann Vice Chairman-Supervisory Board
François Diederich Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BASF-12.98%87 289
DOWDUPONT-4.59%157 363
ROYAL DSM15.30%19 571
EVONIK INDUSTRIES-0.03%17 637
GROUPE BRUXELLES LAMBERT-0.12%17 031
MITSUBISHI CHEMICAL HOLDINGS CORP.-17.21%13 525